Search

Your search keyword '"Tawesak Tanwandee"' showing total 4 results
Start Over Author "Tawesak Tanwandee" Publisher sage journals
4 results on '"Tawesak Tanwandee"'

1. INC280X2201_HCC_Manuscript_Supplementary_Figure_S1 – Supplemental material for A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma

Author

Shukui Qin, Chan, Stephen Lam, Wattana Sukeepaisarnjaroen, Guohong Han, Choo, Su Pin, Virote Sriuranpong, Hongming Pan, Yau, Thomas, Yabing Guo, Minshan Chen, Zhenggang Ren, Jianming Xu, Chia-Jui Yen, Zhong-Zhe Lin, Manenti, Luigi, Gu, Yi, Yongjian Sun, Tiedt, Ralph, Hao, Lu, Wenjie Song, and Tawesak Tanwandee

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 111299 Oncology and Carcinogenesis not elsewhere classified
Abstract

Supplemental material, INC280X2201_HCC_Manuscript_Supplementary_Figure_S1 for A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma by Shukui Qin, Stephen Lam Chan, Wattana Sukeepaisarnjaroen, Guohong Han, Su Pin Choo, Virote Sriuranpong, Hongming Pan, Thomas Yau, Yabing Guo, Minshan Chen, Zhenggang Ren, Jianming Xu, Chia-Jui Yen, Zhong-Zhe Lin, Luigi Manenti, Yi Gu, Yongjian Sun, Ralph Tiedt, Lu Hao, Wenjie Song and Tawesak Tanwandee in Therapeutic Advances in Medical Oncology

Published
2019
Full Text
View/download PDF

2. INC280X2201_HCC_Manuscript_Supplementary_Table_S2 – Supplemental material for A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma

Author

Shukui Qin, Chan, Stephen Lam, Wattana Sukeepaisarnjaroen, Guohong Han, Choo, Su Pin, Virote Sriuranpong, Hongming Pan, Yau, Thomas, Yabing Guo, Minshan Chen, Zhenggang Ren, Jianming Xu, Chia-Jui Yen, Zhong-Zhe Lin, Manenti, Luigi, Gu, Yi, Yongjian Sun, Tiedt, Ralph, Hao, Lu, Wenjie Song, and Tawesak Tanwandee

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 111299 Oncology and Carcinogenesis not elsewhere classified
Abstract

Supplemental material, INC280X2201_HCC_Manuscript_Supplementary_Table_S2 for A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma by Shukui Qin, Stephen Lam Chan, Wattana Sukeepaisarnjaroen, Guohong Han, Su Pin Choo, Virote Sriuranpong, Hongming Pan, Thomas Yau, Yabing Guo, Minshan Chen, Zhenggang Ren, Jianming Xu, Chia-Jui Yen, Zhong-Zhe Lin, Luigi Manenti, Yi Gu, Yongjian Sun, Ralph Tiedt, Lu Hao, Wenjie Song and Tawesak Tanwandee in Therapeutic Advances in Medical Oncology

Published
2019
Full Text
View/download PDF

3. INC280X2201_HCC_Manuscript_Supplementary_Table_S3 – Supplemental material for A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma

Author

Shukui Qin, Chan, Stephen Lam, Wattana Sukeepaisarnjaroen, Guohong Han, Choo, Su Pin, Virote Sriuranpong, Hongming Pan, Yau, Thomas, Yabing Guo, Minshan Chen, Zhenggang Ren, Jianming Xu, Chia-Jui Yen, Zhong-Zhe Lin, Manenti, Luigi, Gu, Yi, Yongjian Sun, Tiedt, Ralph, Hao, Lu, Wenjie Song, and Tawesak Tanwandee

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 111299 Oncology and Carcinogenesis not elsewhere classified
Abstract

Supplemental material, INC280X2201_HCC_Manuscript_Supplementary_Table_S3 for A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma by Shukui Qin, Stephen Lam Chan, Wattana Sukeepaisarnjaroen, Guohong Han, Su Pin Choo, Virote Sriuranpong, Hongming Pan, Thomas Yau, Yabing Guo, Minshan Chen, Zhenggang Ren, Jianming Xu, Chia-Jui Yen, Zhong-Zhe Lin, Luigi Manenti, Yi Gu, Yongjian Sun, Ralph Tiedt, Lu Hao, Wenjie Song and Tawesak Tanwandee in Therapeutic Advances in Medical Oncology

Published
2019
Full Text
View/download PDF

4. INC280X2201_HCC_Manuscript_Supplementary_Table_S1 – Supplemental material for A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma

Author

Shukui Qin, Chan, Stephen Lam, Wattana Sukeepaisarnjaroen, Guohong Han, Choo, Su Pin, Virote Sriuranpong, Hongming Pan, Yau, Thomas, Yabing Guo, Minshan Chen, Zhenggang Ren, Jianming Xu, Chia-Jui Yen, Zhong-Zhe Lin, Manenti, Luigi, Gu, Yi, Yongjian Sun, Tiedt, Ralph, Hao, Lu, Wenjie Song, and Tawesak Tanwandee

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 111299 Oncology and Carcinogenesis not elsewhere classified
Abstract

Supplemental material, INC280X2201_HCC_Manuscript_Supplementary_Table_S1 for A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma by Shukui Qin, Stephen Lam Chan, Wattana Sukeepaisarnjaroen, Guohong Han, Su Pin Choo, Virote Sriuranpong, Hongming Pan, Thomas Yau, Yabing Guo, Minshan Chen, Zhenggang Ren, Jianming Xu, Chia-Jui Yen, Zhong-Zhe Lin, Luigi Manenti, Yi Gu, Yongjian Sun, Ralph Tiedt, Lu Hao, Wenjie Song and Tawesak Tanwandee in Therapeutic Advances in Medical Oncology

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results